Increased serum bilirubin levels coincident with heart failure decompensation indicate the need for intravenous inotropic agents

International Heart Journal

Volumn 48, Issue 2, 2007, Pages 195-204

  Shinagawa, Hisahito ^a   Inomata, Takayuki ^a   Koitabashi, Toshimi ^a   Nakano, Hironari ^a   Takeuchi, Ichiro ^a   Osaka, Tsutomu ^a   Nishii, Mototsugu ^a   Takehana, Hitoshi ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bilirubin; Heart failure; Inotropic agents; Low cardiac output

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ATRIAL NATRIURETIC FACTOR ALPHA; AZOSEMIDE; BILIRUBIN; CREATININE; DOBUTAMINE; DOPAMINE; FUROSEMIDE; INOTROPIC AGENT; LOPRINONE; MILRINONE; SPIRONOLACTONE; TORASEMIDE; TRICHLORMETHIAZIDE;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIURESIS; DRUG MEGADOSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

AGED; BILIRUBIN; BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; COHORT STUDIES; DIURETICS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEEDS ASSESSMENT; TREATMENT OUTCOME;

EID: 34247190210     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.195     Document Type: Article

References (15)

1. Mazza A, Tikhonoff V, Casiglia E, Pessina AC. Predictors of congestive heart failure mortality in elderly people from the general population. Int Heart J 2005; 46: 419-31.
2. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: e1-82. (Review)
3. Grady KL, Dracup K, Kennedy G, et al. Team management of patient with heart failure: A statement for healthcare professionals from The Cardiovascular Nursing Council of the American Heart Association. Circulation 2000; 102: 2443-56.
4. Segawa T, Nakamura M, Itai K, Onoda T, Okayama A, Hiramori K. Plasma, B-type natriuretic peptide levels and risk factors for congestive heart failure in a Japanese general population. Int Heart J 2005; 46: 465-75.
5. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
6. Kubo, SH, Walter BA, John DH, Clark M, Cody RJ. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med 1987; 147: 1227-30.
7. Sherlock S, Dooley J. The hepatic artery and hepatic veins: the liver in circulatory, failure. In: Sherlock S, Dooley J, ed. Diseases of the Liver and Biliary System. 11th ed. Oxford, England: Blackwell Science Publications; 2002: 199-203.
8. Shinagawa H, Inomata T, Koitabashi T, et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Eur Heart J 2005; 26 (Abstract Supplement): 73.
9. Ho KK, Prinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiolol 1993; 22 (Suppl A): 6A-13.
10. Benet LZ. Pharmacokinetics/pharmacodynamics of furosemide in man: a review. J Pharmacokinet Biopharm 1979; 7: 1-27.
11. Thackray S, Easthaugh J, Freemantle N, Cleland JG. The effectiveness relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis. Eur J Heart Fail 2002; 4: 515-29.
12. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002; 90: 1405-9.
13. Bayram M, De Luca L, Massie MB, Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 2005; 96: 47G-58. (Review)
14. Cleland JG, Ghosh J, Freemantle N, et al. Clinical trials update and cumulative meta-analyses from the American College of Cardiolgy: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail 2004; 6: 501-8.
15. Ander DS, Jaggi M, Rivers E, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol. 1998; 82: 888-91.